Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

NCT06050317 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer

Interventions

DRUG: Sintilimab Plus mFFN or NALIRIFOX and Radiation

Sponsor

Shandong Cancer Hospital and Institute